Home » News » CROs/Service Providers » Agilux Laboratories expands in vivo pharmacokinetics services

Agilux Laboratories expands in vivo pharmacokinetics services

Monday, December 9, 2013

New England-based CRO Agilux Laboratories, a provider of drug metabolism and pharmacokinetics (DMPK) services to sponsors, has expanded its in vivo pharmacokinetics services to support clients’ demands and increased service requirements. The space expansion will allow Agilux to significantly increase its capacity and volume, while maintaining fast study starts.

Agilux has more than doubled its dedicated vivarium space, which enables an increase in all in vivo services with potential for additional species and genders. Agilux immediately is able to utilize 50% of the new space, with additional capacity available to its client base.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!